Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes

Go back to Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes
(NASDAQ: KURA) Delayed: 9.61 -0.25 (2.54%)
Previous Close $9.86    52 Week High $8.90 
Open $9.80    52 Week Low $2.50 
Day High $9.84    P/E N/A 
Day Low $9.28    EPS $0.00 
Volume 1,564,980